SCIENCE IN THE NEWS DAILY
Study Suggests Drug Can Cut Risk of Cancer's Return
from the Baltimore Sun
CHICAGO (Associated Press) - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.
It is the first large study to affirm wider anti-cancer hopes for Zometa and other bone-building drugs called bisphosphonates. Zometa, made by Novartis AG, is used now for cancers that have already spread to the bone.
The new study involved 1,800 premenopausal women taking hormone treatments for early-stage breast cancer. Zometa cut by one-third the chances that cancer would recur—in their bones or anywhere else.
Read more ...
Connect With Us:
VIDEO: From Biology to Military History: Patterns in Animal Weaponry
What are the parallels between an ancient war ship and a dung beetle? More than you would think, actually! Douglas J. Emlen, PhD, has a unique perspective on animal weaponry that looks at patterns in military history.
To view all multimedia content, click "Latest Multimedia"!
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.